FDA 483 - Robert Hayashi M.D - July 08, 2022
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Robert Hayashi M.D., a clinical investigator at Washington University School of Medicine in Saint Louis, MO, revealed significant deviations from an investigational plan. The inspection found failures to adhere to protocol requirements, including the omission of specific treatments for a pediatric subject and the administration of investigational product to an ineligible subject. These findings indicate a lack of adherence to clinical trial protocols.
ID · e6795bc6-721c-43c0-b4f5-d5a4270a1235